Can I read Abraxane Patent Infringement Complaint on EtoBox?

Abraxane Patent Infringement Complaint by iphawk is a document available to read on EtoBox.

What is Abraxane Patent Infringement Complaint about?

This document is a complaint filed by Abraxis BioScience, LLC and Celgene Corporation against Actavis LLC for patent infringement. Celgene holds approved NDAs for the drug ABRAXANE, which is covered by four patents owned by Abraxis (the patents-in-suit). Actavis filed an ANDA seeking approval to market a generic version of ABRAXANE before the patents expire, which Celgene alleges would infringe the patents. Celgene brings this suit under patent laws, asserting Actavis

Author

iphawk

Language

EN